Onward Medical NVONWRF 37 Pretax Margin % is -746.08% as of Dec. 2025. GuruFocus rates ONWRF with a GF Score™ of 37/100 and a GF Value™ of $154.42 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 944 Biotechnology companies, Onward Medical NV ranks worse than 79.45% on this metric.
The historical rank and industry rank for Onward Medical NV's Pretax Margin % or its related term are showing as below:
ONWRF'
s Pretax Margin % Range Over the Past 10 Years
Min: -53050 Med: -23932.99 Max: -1097.25
Current: -1097.25
ONWRF's Pretax Margin % is ranked worse than 79.45% of 944
companies
in the Biotechnology industry
Industry Median: -90.5
vs ONWRF: -1097.25
Onward Medical NV (OTCPK:ONWRF) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Onward Medical NV Pretax Margin % Related Terms
Onward Medical NV Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Onward Medical NV's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ONWRF vs VRTX, REGN, ALNY: Pretax Margin % Comparison
For the Biotechnology subindustry, Onward Medical NV's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Onward Medical NV Pretax Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Onward Medical NV's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Onward Medical NV's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Onward Medical NV (ONWRF) has a Pretax Margin % of -746.08% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Onward Medical NV and its competitors. According to the industry distribution chart, Onward Medical NV ranks #750 out of 944 companies in the Biotechnology industry, placing it in the top 79.4%.
Is Onward Medical NV's Pretax Margin % too high?
Onward Medical NV's current Pretax Margin % is -746.08%. Based on the distribution chart, Onward Medical NV ranks #750 out of 944 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Onward Medical NV has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Onward Medical NV's Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Onward Medical NV ranks #750 out of 944 companies for Pretax Margin %. This places Onward Medical NV in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Onward Medical NV and its competitors. Onward Medical NV's current Pretax Margin % is -746.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onward Medical NV stock overvalued right now?
Based on GuruFocus' analysis, Onward Medical NV (ONWRF) is currently considered Possible Value Trap. The stock's GF Value™ is $154.42, compared to a current price of $2.96 — trading 98.1% below its estimated fair value. The current Pretax Margin % is -746.08%. Onward Medical NV's overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Onward Medical NV (ONWRF), the current Pretax Margin % is -746.08% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Onward Medical NV (ONWRF) Overvalued in 2026?
Based on GuruFocus' analysis, Onward Medical NV stock appears to be undervalued.
The current stock price of $2.96 is trading 98.1% below its estimated GF Value™ of $154.42.
GuruFocus considers Onward Medical NV to be Possible Value Trap.
Key valuation signals for ONWRF:
Pretax Margin %: -746.08%
GF Value™: $154.42 vs. price of $2.96 (98.1% below fair value)
No single metric tells the full story. See the ONWRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Onward Medical NV is developing and commercializing therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company's technology platforms are based on ONWARD ARC Therapy (ARC Therapy), targeted, programmed electrical stimulation of the spinal cord designed to restore movement, independence, and health in people with SCI.
37GF Score
Get the complete analysis for ONWRF
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ONWRF has been successfully added to your 
